Urinary trivalent methylated arsenic species in a population chronically exposed to inorganic arsenic.
Chronic exposure to inorganic arsenic (iAs) has been associated with increased risk of various forms of cancer and of noncancerous diseases. Metabolic conversions of iAs that yield highly toxic and genotoxic methylarsonite (MAsIII) and dimethylarsinite (DMAsIII) may play a significant role in determining the extent and character of toxic and cancer-promoting effects of iAs exposure. In this study we examined the relationship between urinary profiles of MAsIII and DMAsIII and skin lesion markers of iAs toxicity in individuals exposed to iAs in drinking water. The study subjects were recruited among the residents of an endemic region of central Mexico. Drinking-water reservoirs in this region are heavily contaminated with iAs. Previous studies carried out in the local populations have found an increased incidence of pathologies, primarily skin lesions, that are characteristic of arseniasis. The goal of this study was to investigate the urinary profiles for the trivalent and pentavalent As metabolites in both high- and low-iAs-exposed subjects. Notably, methylated trivalent arsenicals were detected in 98% of analyzed urine samples. On average, the major metabolite, DMAsIII, represented 49% of total urinary As, followed by DMAsV (23.7%), iAsV (8.6%), iAsIII (8.5%), MAsIII (7.4%), and MAsV (2.8%). More important, the average MAsIII concentration was significantly higher in the urine of exposed individuals with skin lesions compared with those who drank iAs-contaminated water but had no skin lesions. These data suggest that urinary levels of MAsIII, the most toxic species among identified metabolites of iAs, may serve as an indicator to identify individuals with increased susceptibility to toxic and cancer-promoting effects of arseniasis.
Valenzuela
Olga L
OL
Seccion de Toxicología, Cinvestav-IPN, México DF, México.
Borja-Aburto
Victor H
VH
Garcia-Vargas
Gonzalo G
GG
Cruz-Gonzalez
Martha B
MB
Garcia-Montalvo
Eliud A
EA
Calderon-Aranda
Emma S
ES
Del Razo
Luz M
LM
D000293:Adolescent; D000328:Adult; D020261:Arsenic Poisoning / Q000503:physiopathology*; D001152:Arsenicals / Q000378:metabolism / Q000652:urine*; D002101:Cacodylic Acid / Q000031:analogs & derivatives* / Q000652:urine*; D003430:Cross-Sectional Studies; D004781:Environmental Exposure; D005260:Female; D006801:Humans; D008297:Male; D008745:Methylation; D008800:Mexico; D008875:Middle Aged; D009369:Neoplasms / Q000139:chemically induced; D018570:Risk Assessment; D014881:Water Supply
D001152:Arsenicals; C472511:dimethylarsinous acid; C501996:methylarsonite; D002101:Cacodylic Acid
Environ Pollut. 1990;64(2):143-53
15092299
Toxicol Appl Pharmacol. 2001 May 1;172(3):225-32
11312651
Chem Res Toxicol. 2001 Mar;14(3):305-11
11258980
Toxicol Appl Pharmacol. 2004 Aug 1;198(3):319-26
15276411
Chem Res Toxicol. 2001 Aug;14(8):1051-7
11511179
Comp Biochem Physiol C Toxicol Pharmacol. 2002 Mar;131(3):355-65
11912060
Chem Res Toxicol. 2002 May;15(5):692-8
12018991
Chem Res Toxicol. 2001 Apr;14(4):355-61
11304123
Int J Dermatol. 1997 Apr;36(4):241-50
9169318
J Pharmacol Exp Ther. 1997 Jul;282(1):192-200
9223554
Chem Res Toxicol. 2001 Dec;14(12):1604-11
11743743
Chem Res Toxicol. 2002 Sep;15(9):1150-7
12230408
Hum Exp Toxicol. 1994 Dec;13(12):839-47
7718303
Chem Res Toxicol. 2001 Oct;14(10):1446-52
11599937
Arch Toxicol. 2000 Aug;74(6):289-99
11005674
Bull Environ Contam Toxicol. 1997 Oct;59(4):583-9
9307423
Arch Toxicol. 1997;71(4):211-7
9101036
Toxicol Appl Pharmacol. 2001 Aug 1;174(3):282-93
11485389
Hum Pathol. 1973 Dec;4(4):469-85
4750817
Environ Health Perspect. 2002 Oct;110 Suppl 5:767-71
12426129
Toxicology. 2000 Feb 21;143(2):155-66
10755702
Cancer Epidemiol Biomarkers Prev. 2000 Nov;9(11):1259-62
11097236
Chem Res Toxicol. 2004 Mar;17(3):404-9
15025511
Chem Res Toxicol. 1997 Jan;10(1):27-33
9074799
Environ Health Perspect. 2000 Nov;108(11):1015-8
11102289
Chem Res Toxicol. 2000 Aug;13(8):693-7
10956055
Hum Toxicol. 1983 Jan;2(1):121-33
6840787
Toxicol Appl Pharmacol. 2004 Aug 1;198(3):458-67
15276427
Chem Res Toxicol. 2001 Apr;14(4):371-8
11304125
Toxicol Sci. 2003 Jul;74(1):22-31
12730608
Chem Res Toxicol. 2002 Dec;15(12):1627-34
12482246
J Biol Chem. 2002 Mar 29;277(13):10795-803
11790780
Environ Health Perspect. 1995 Jul-Aug;103(7-8):684-9
7588479
J Natl Cancer Inst. 1968 Mar;40(3):453-63
5644201